EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases

Tian Tian, Monan Liu, Peter J Little, Hans Strijdom, Jianping Weng, Suowen Xu iD

Research · 2025-01 · 8

DOI: 10.34133/research.0832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research, online erschienen am 19.08.2025. Verfasst von Tian Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sc…. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, the Program for Innovative Research Team of The First Affiliated Hospital of USTC, Anhui Provincial Natural Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth differentiation factor 15 (GDF15), a TGF-β superfamily member and stress-responsive cytokine, plays a critical role in metabolism and regulation of inflammation. This review summarizes the expression, distribution, structure, processing, and secretion of GDF15. We also discuss multilayered regulatory networks governing GDF15 expression, including ATF4/CHOP, AMPK, EGR1, EZH2, PPARγ, NRF2, ERRγ, and p53, as well as posttranscriptional regulator CNOT6L. The GFRAL receptor is central to its function, mediating the anorexigenic and metabolic effects of GDF15. This review synthesizes evidence linking GDF15 to obesity, diabetes, cardiovascular diseases, metabolic liver disorders, cachexia, sarcopenia, and aging while exploring its interactions with key metabolic factors including FGF21, GLP-1, leptin, and glucocorticoids. Lifestyle interventions such as ketogenic, high-fat diets, and exercise modulate GDF15 levels, underscoring its role in pan-metabolic health. Pharmacologically, various agents—including anti-hyperglycemic agents and natural compounds—induce GDF15 expression, implicating their therapeutic potential in cardiometabolic diseases. We comprehensively evaluate current advances in GDF15-targeted drug development, including monoclonal antibodies, fusion proteins, and small-molecule drugs, to provide a scientific foundation for innovative therapies. Finally, we outline unresolved issues in GDF15 biology and therapeutics, such as the exploration of peripheral receptors, contradictory findings in studies of cardiometabolic diseases, and the persistent challenges in developing GDF15-targeted therapeutics.

Autor:innen und Institutionen

  • Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, He…
  • Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Hefei 230001, China.
  • School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Woolloongabba, QLD4102, Australia.
  • Centre for Cardio-metabolic Research in Africa, Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

ORCID-Profile: Suowen Xu

Förderung

  • National Natural Science Foundation of China
  • the Program for Innovative Research Team of The First Affiliated Hospital of USTC
  • Anhui Provincial Natural Science Foundation
  • USTC Research Funds of the Double First-Class Initiative
  • the Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM

Zitieren

APA

Tian, T., Liu, M., Little, P. J., Strijdom, H., Weng, J., & Xu, S. (2025). Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases. Research, 8. https://doi.org/10.34133/research.0832

Vancouver

Tian T, Liu M, Little PJ, Strijdom H, Weng J, Xu S. Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases. Research. 2025;8. doi:10.34133/research.0832

BibTeX
@article{Tian2025,
  author = {Tian, Tian and Liu, Monan and Little, Peter J and Strijdom, Hans and Weng, Jianping and Xu, Suowen},
  title = {Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases},
  journal = {Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/research.0832}
}
Kostenlos starten →